+ Watch ONVO
on My Watchlist
3D ORGAN Developement has huge potential for medical health.
Still believe it's a good niche area for this technology, the company seems to be making critical collaborations work. Any technology that can accelerate the drug discovery process is going to succeed.
This is bleeding edge technology that combines the paradigm shift of 3D printing with bio-medical science. They have real products, but are not yet in manufacturing mode. This is one of two equities I decided would comprise my more potential than tangible products slice of the pie.
Limited market for liver assay product, and will compete with established players. Potential market of (optimistically) a few million dollars a year does not justify a nearly billion-dollar market cap. Other products still in the far future. Management enthusiastically selling shares at these prices.
Very promising field...
3d printing organs, cool!
The long term possibilities of this cutting edge company are high, but so are the risks. However, I still like the companies model.
Though I doubt much profit to be reaped in the first few years, I think the ideas and the technology that this company will develop will be well worth the wait.
ONVO is about as disruptive a technology as it gets: 3-D printing combined with biomedical science.
Boiler room, they don't print s**t !
The future that now seems like science fiction.
3D printed livers baby!
They're printing living tissue O_O
Expecting the speculation to be heavy and positive on ONVO in Q1 and Q2 2014. Ride the 3D momentum on the edge.
Their trademark could give them control of this market.
This company has what seems to be a foot in the door of a very lucrative market. The organs that the print can have a huge impact on the future health of the world. Testing drugs on live tissues that can be reproduced at will, will increase the rate and effectiveness of pharmacalogical research. This company may even be able to print "New" organs for those who have failing ones.This technology still needs to be proven a little bit but I have a decent position in this slightly speculative stock.
Has a lot going for it...20-25 by end of 2014.
After their 3 D Liver they will develope a 3 D Heart.
This is the future !
leading edge technology in 3d printing and medical advances
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions